Phagenesis

Developer of medical devices for the treatment of Neurogenic dysphagia

placeManchester, England, United Kingdom calendar_todayFounded 2007 groups22 employees language phagenesis.com

Registered entities

Investor mix

12 investors on record; lead investors include Sectoral, EQT; 1 has since exited.

Investor typeCountShare
Venture capital650%
Private equity217%
Accelerator & incubator18%
Other / undisclosed325%
Coming soon